These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 22239439)

  • 41. Repression of malignant tumor progression upon pharmacologic IGF1R blockade in a mouse model of insulinoma.
    Zumsteg A; Caviezel C; Pisarsky L; Strittmatter K; García-Echeverría C; Hofmann F; Christofori G
    Mol Cancer Res; 2012 Jun; 10(6):800-9. PubMed ID: 22562956
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Growth-promoting interaction of IGF-II with the insulin receptor during mouse embryonic development.
    Louvi A; Accili D; Efstratiadis A
    Dev Biol; 1997 Sep; 189(1):33-48. PubMed ID: 9281335
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diverse functions of IGF/insulin signaling in malignant and noncancerous prostate cells: proliferation in cancer cells and differentiation in noncancerous cells.
    Heidegger I; Ofer P; Doppler W; Rotter V; Klocker H; Massoner P
    Endocrinology; 2012 Oct; 153(10):4633-43. PubMed ID: 22903612
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeting the type 1 insulin-like growth factor receptor as anti-cancer treatment.
    Bohula EA; Playford MP; Macaulay VM
    Anticancer Drugs; 2003 Oct; 14(9):669-82. PubMed ID: 14551500
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combination therapy approaches to target insulin-like growth factor receptor signaling in breast cancer.
    Ochnik AM; Baxter RC
    Endocr Relat Cancer; 2016 Nov; 23(11):R513-R536. PubMed ID: 27733416
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The type 1 insulin-like growth factor receptor pathway.
    Chitnis MM; Yuen JS; Protheroe AS; Pollak M; Macaulay VM
    Clin Cancer Res; 2008 Oct; 14(20):6364-70. PubMed ID: 18927274
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The IGF1 Signaling Pathway: From Basic Concepts to Therapeutic Opportunities.
    Werner H
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834331
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Insulin-like growth factor receptor inhibitors: baby or the bathwater?
    Yee D
    J Natl Cancer Inst; 2012 Jul; 104(13):975-81. PubMed ID: 22761272
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oncogenic fusion proteins adopt the insulin-like growth factor signaling pathway.
    Werner H; Meisel-Sharon S; Bruchim I
    Mol Cancer; 2018 Feb; 17(1):28. PubMed ID: 29455671
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Involvement of Igf1r in Bronchiolar Epithelial Regeneration: Role during Repair Kinetics after Selective Club Cell Ablation.
    López IP; Piñeiro-Hermida S; Pais RS; Torrens R; Hoeflich A; Pichel JG
    PLoS One; 2016; 11(11):e0166388. PubMed ID: 27861515
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Igf1R/InsR function is required for axon extension and corpus callosum formation.
    Jin J; Ravindran P; Di Meo D; Püschel AW
    PLoS One; 2019; 14(7):e0219362. PubMed ID: 31318893
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Systems Analysis of Insulin and IGF1 Receptors Networks in Breast Cancer Cells Identifies Commonalities and Divergences in Expression Patterns.
    Sarfstein R; Yeheskel A; Sinai-Livne T; Pasmanik-Chor M; Werner H
    Front Endocrinol (Lausanne); 2020; 11():435. PubMed ID: 32733384
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Insulin/Insulin-like growth factors in cancer: new roles for the aryl hydrocarbon receptor, tumor resistance mechanisms, and new blocking strategies.
    Salisbury TB; Tomblin JK
    Front Endocrinol (Lausanne); 2015; 6():12. PubMed ID: 25699021
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeting the insulin growth factor receptor 1.
    Arnaldez FI; Helman LJ
    Hematol Oncol Clin North Am; 2012 Jun; 26(3):527-42, vii-viii. PubMed ID: 22520978
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The glycolytic inhibitor 2-deoxyglucose activates multiple prosurvival pathways through IGF1R.
    Zhong D; Xiong L; Liu T; Liu X; Liu X; Chen J; Sun SY; Khuri FR; Zong Y; Zhou Q; Zhou W
    J Biol Chem; 2009 Aug; 284(35):23225-33. PubMed ID: 19574224
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-insulin-like growth factor therapy in breast cancer.
    Yee D
    J Mol Endocrinol; 2018 Jul; 61(1):T61-T68. PubMed ID: 29378771
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inflammation in the hippocampus affects IGF1 receptor signaling and contributes to neurological sequelae in rheumatoid arthritis.
    Andersson KME; Wasén C; Juzokaite L; Leifsdottir L; Erlandsson MC; Silfverswärd ST; Stokowska A; Pekna M; Pekny M; Olmarker K; Heckemann RA; Kalm M; Bokarewa MI
    Proc Natl Acad Sci U S A; 2018 Dec; 115(51):E12063-E12072. PubMed ID: 30509997
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Advances in insulin-like growth factor biology and -directed cancer therapeutics.
    Fettig LM; Yee D
    Adv Cancer Res; 2020; 147():229-257. PubMed ID: 32593402
    [TBL] [Abstract][Full Text] [Related]  

  • 59. IGF-1 receptor inhibitors in clinical trials--early lessons.
    Weroha SJ; Haluska P
    J Mammary Gland Biol Neoplasia; 2008 Dec; 13(4):471-83. PubMed ID: 19023648
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects and potential mechanisms of IGF1/IGF1R in the liver fibrosis: A review.
    Gui R; Li W; Li Z; Wang H; Wu Y; Jiao W; Zhao G; Shen Y; Wang L; Zhang J; Chen S; Hao L; Cheng Y
    Int J Biol Macromol; 2023 Nov; 251():126263. PubMed ID: 37567540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.